Plasminogen Activator Inhibitor Type-1 (Part One)
Plasminogen Activator Inhibitor Type-1 (Part Two)
Short-Term Comparative Outcomes Associated with the Use of GP IIb/IIIa Antagonists in Patients Undergoing Coronary Intervention
Elevation in Serum Troponin I Predicts the Benefit of Tirofiban
Relationship Between the Heparin Management Test and the HemoTec Activated Clotting Time in Patients Undergoing Percutaneous Coronary Intervention
Augmentation of In-Vitro Clot Dissolution by Low Frequency High-Intensity Ultrasound Combined with Antiplatelet and Antithrombotic Drugs
Noninvasive Transthoracic Low Frequency Ultrasound Augments Thrombolysis in a Canine Model of Acute Myocardial Infarction – Evaluation of the Extent of ST-Segment Resolution
Low Molecular Weight Heparin Therapy for Percutaneous Coronary Intervention
Applying Scientific Criteria to Therapeutic Interchange
Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic Uremic Syndrome (HUS)